MedPath

Tumor Marker CA-19-9, CEA,CA125, CA242 for early diagnosis and predicting prognosis in gall bladder cancer patient

Not Applicable
Conditions
Health Condition 1: K828- Other specified diseases of gallbladder
Registration Number
CTRI/2019/03/018064
Lead Sponsor
Director
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients suspicious for gallbladder cancer ( GB polyp, irregular thick wall GB, GB mass, porcelain GB) basis of radio logical imaging

Exclusion Criteria

1.Patients presented with GB mass with Jaundice

2.Disseminated GBC

3.Patients already received Radiotherapy/ Neoadjuvant chemotherapy

4.Synchronous second primary cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Access whether the combined use of tumor markers increase the diagnostic sensitivity and specificity for gallbladder cancerTimepoint: 15th April 2019 (At 1 year)
Secondary Outcome Measures
NameTimeMethod
To compare the tumor marker level between carcinoma of gall bladder and benign gall bladder diseases.Timepoint: January 20121 (at 2 years)
© Copyright 2025. All Rights Reserved by MedPath